Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Grether

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 24, 2024
Involvement of CB<sub>1</sub> and CB<sub>2</sub> receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male miceClaudia Gonzalo-Consuegra, Irene Santos-García, Laura García-Toscano, et al.
Journal of Medicinal Chemistry|January 28, 2022
Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for NeuroimagingYingfang He, Matthias Schild, Uwe Grether, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2010
Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activityJens-Uwe Peters, Holger Kühne, Henrietta Dehmlow, et al.
Chemmedchem|March 28, 2009
Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonistsUwe Grether, Agnes Bénardeau, Jörg Benz, et al.
Neuron|September 5, 2025
The "five-star matrix" for patient-centric drug discovery and development in neuroscienceAxel Pähler, Eoin C O'Connor, Hayley Binch, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2009
Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetesAgnes Bénardeau, Jörg Benz, Alfred Binggeli, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonistSong Feng, Minmin Yang, Zhenshan Zhang, et al.
Chembiochem : a European Journal of Chemical Biology|January 27, 2023
EFMC: Trends in Medicinal Chemistry and Chemical BiologyYves P Auberson, Paola B Arimondo, Maria Duca, et al.
Cell Communication and Signaling : CCS|October 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB<sub>2</sub> receptor activation in experimental ALS in male miceMarta Gómez-Almería, Claudia Gonzalo-Consuegra, Carmen Rodríguez-Cueto, et al.
Biochemistry|August 7, 2025
Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β<sub>2</sub>-Adrenoceptor AgonistsNgan T N Phan, Leire Borrega-Roman, Bradley L Hoare, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 24, 2024
Involvement of CB<sub>1</sub> and CB<sub>2</sub> receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male miceClaudia Gonzalo-Consuegra, Irene Santos-García, Laura García-Toscano, et al.
Journal of Medicinal Chemistry|January 28, 2022
Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for NeuroimagingYingfang He, Matthias Schild, Uwe Grether, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2010
Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activityJens-Uwe Peters, Holger Kühne, Henrietta Dehmlow, et al.
Chemmedchem|March 28, 2009
Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonistsUwe Grether, Agnes Bénardeau, Jörg Benz, et al.
Neuron|September 5, 2025
The "five-star matrix" for patient-centric drug discovery and development in neuroscienceAxel Pähler, Eoin C O'Connor, Hayley Binch, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2009
Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetesAgnes Bénardeau, Jörg Benz, Alfred Binggeli, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonistSong Feng, Minmin Yang, Zhenshan Zhang, et al.
Chembiochem : a European Journal of Chemical Biology|January 27, 2023
EFMC: Trends in Medicinal Chemistry and Chemical BiologyYves P Auberson, Paola B Arimondo, Maria Duca, et al.
Cell Communication and Signaling : CCS|October 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB<sub>2</sub> receptor activation in experimental ALS in male miceMarta Gómez-Almería, Claudia Gonzalo-Consuegra, Carmen Rodríguez-Cueto, et al.
Biochemistry|August 7, 2025
Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β<sub>2</sub>-Adrenoceptor AgonistsNgan T N Phan, Leire Borrega-Roman, Bradley L Hoare, et al.
Pageof 10